< Back to Find a Trial

A Multicenter, Open-Label, Long-Term Extension Of Phase III Studies (BN29552/BN29553) Of Crenezumab In Patients With Alzheimer's Disease (BN40031)

ID

NCT03491150

Condition Studied

Alzheimer's Disease

Phase

Phase III

Status

Closed

Intervention

Crenezumab (RO5490245)

Principal Investigator

Adam Boxer, MD, PhD

[email protected]

415 - 476 - 0668

Please go to ClinicalTrials.gov for more information.